[S6] Therapeutic Radiochemistry | WTTC20

Advanced Search

Session Details

Regular Session

[S6]Therapeutic Radiochemistry

Tue. Aug 25, 2026 3:30 PM - 4:30 PM JST
Tue. Aug 25, 2026 6:30 AM - 7:30 AM UTC

Noh Theater (1F)

3:30 PM - 3:45 PM JST(6:30 AM - 6:45 AM UTC)

[S6-01]Standardization of ²¹¹At chemical species for the Targeted Alpha Therapy

*Shigeki Watanabe¹, Masashi Murakami², Ichiro Sasaki¹, Feng Yin², Kazuhiro Ooe², Yukiyoshi Kon², Tomoyuki Ohya³, Jun Ichinose³, Katsuyuki Minegishi³, Kotaro Nagatsu³, Tetsuya Sakashita¹, Atsushi Toyoshima², Noriko S Ishioka¹ (1. Takasaki Institute for Advanced Quantum Science, National Institute for Quantum Science and Technology (Japan), 2. The University of Osaka (Japan), 3. Institute for Quantum Medical Science, QST (Japan))

3:45 PM - 4:00 PM JST(6:45 AM - 7:00 AM UTC)

[S6-02]228Th Generators for the Production of 212Pb

*Kyle Wayne Stewart¹, Tuan Tran¹, David Bauer², Jason S. Lewis¹, Serge K. Lyashchenko¹ (1. Memorial Sloan Kettering Cancer Center (USA), 2. University of Missouri (USA))

4:00 PM - 4:15 PM JST(7:00 AM - 7:15 AM UTC)

[S6-03]Routine Production of cGMP ²²⁵Ac from ²²⁹Th

Dominic Maertens^1,2, *Blake Tamboline¹, Hilde Lenaerts¹, Samy Bertrand¹ (1. PanTera nv (Belgium), 2. KU Leuven (Belgium))

4:15 PM - 4:30 PM JST(7:15 AM - 7:30 AM UTC)

[S6-04]Targeted radionuclide therapy via in-cell reaction with cancer metabolites

*Yudai Ode¹, Akihiro Ishiwata¹, Katsunori Tanaka^1,2 (1. Biofunctional Synthetic Chemistry Laboratory, RIKEN Pioneering Research Institute (Japan), 2. School of Materials and Chemical Technology, Institute of Science Tokyo (Japan))

Back to Category List